Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD
Articolo
Data di Pubblicazione:
2021
Abstract:
Inflammatory bowel diseases (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), are chronic and disabling disorders. Prospective disease-modification trials to prevent disease progression are eagerly awaited. However, disease progression is not clearly defined. The objective of the Selecting EndPoInts foR Disease-ModIfication Trials (SPIRIT) initiative was to achieve international expert consensus on the endpoints to be used in future IBD-disease modification trials.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Crohn’s Disease; Disease Progression; Disease Severity; Ulcerative Colitis
Elenco autori:
Le Berre, Catherine; Peyrin-Biroulet, Laurent; SPIRIT-IOIBD study, Group; Spinelli, Antonino
Link alla scheda completa:
Pubblicato in: